Why Nyxoah SA (NYXH) Stock Is Rising

As of 2026-08-13, Nyxoah SA (NYXH) has a next-year EPS growth estimate of 35.68%. Featured in our EPS revision report on 2026-08-13.

Detected 2026-08-06: 27.76% → 34.80%
First flagged by our EPS-revision screen · estimate has since risen to 35.68% (+0.88 pp)

Why NYXH Stock Is Rising

  • +
    EPS Estimate Upgraded: Analysts raised Nyxoah SA's next-year EPS growth estimate from 27.76% to 34.80% on 2026-08-06.
  • Estimate Trending Higher: Since detection, the estimate has moved up a net +0.88 pp to 35.68% across 1 upward revision.
  • ·
    Current-Year Growth: Projected at 49.78%, supporting the forward estimate revision.

News Context

The primary driver is the August 6, 2026 EPS estimate upgrade,

Generated 2026-08-13 · news as of 2026-08-13

Current Snapshot

Sector
Healthcare
Industry
Medical Instruments & Supplies
EPS growth next year
35.68%
EPS growth this year
49.78%
EPS next quarter (est)
-$0.36
Last price
$1.57

EPS Revision History

35.7%27.8%07-1407-2107-2908-0508-13
Next-year EPS growth estimate · latest 30 days · 27 observations
85.5%78.0%07-1407-2107-2908-0508-13
Combined EPS growth (this year + next year) · latest 30 days · 27 observations
DateEPS Next YEPS This YNext Q (est)Price
2026-08-1335.68%49.78%-$0.36$1.57
2026-08-1235.68%49.78%-$0.36$1.58
2026-08-1135.68%49.78%-$0.36$1.59
2026-08-1035.68%49.78%-$0.36$1.58
2026-08-0935.68%49.78%-$0.36$1.47
2026-08-0734.79%50.66%-$0.36$1.47
2026-08-0634.80%50.61%-$0.36$1.31
2026-08-0527.76%50.21%-$0.45$1.41
2026-08-0427.76%50.21%-$0.45$1.45
2026-08-0327.76%50.21%-$0.45$1.46
2026-08-0227.76%50.21%-$0.45$1.40
2026-07-3127.76%50.21%-$0.45$1.40
2026-07-3027.76%50.21%-$0.45$1.41
2026-07-2927.76%50.21%-$0.45$1.39
2026-07-2827.76%50.21%-$0.45$1.43
2026-07-2727.76%50.21%-$0.45$1.40
2026-07-2627.76%50.21%-$0.45$1.40
2026-07-2427.76%50.21%-$0.45$1.40
2026-07-2327.76%50.21%-$0.45$1.47
2026-07-2227.76%50.21%-$0.45$1.53
2026-07-2127.76%50.21%-$0.45$1.54
2026-07-2027.76%50.21%-$0.45$1.56
2026-07-1927.76%50.21%-$0.45$1.57
2026-07-1727.76%50.21%-$0.45$1.57
2026-07-1627.76%50.21%-$0.45$1.62
2026-07-1527.76%50.21%-$0.45$1.61
2026-07-1427.76%50.21%-$0.45$1.58
2026-07-1327.76%50.21%-$0.45$1.64
2026-07-1227.76%50.21%-$0.45$1.71
2026-07-0927.91%50.12%-$0.45$1.67

Reports Featuring NYXH

Recent News

Screen Performance

Aggregate stats across all 1969 tickers our top-EPS-revision screen has flagged over the past 134 days.

Median return since detection
+4.2%
% of tickers in the green
58%
Median return on winners
+21.7%
Large revisions captured
1458

Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.

Also Tracked by Our Screen

Frequently Asked Questions

Why did Nyxoah SA (NYXH) stock go up recently?

Nyxoah SA (NYXH) stock has risen following an analyst upgrade of its next-year EPS growth estimate from 27.76% to 34.80% on 2026-08-06. Since detection, the estimate has moved up a net +0.88 pp to 35.68%. EPS estimate upgrades are among the strongest leading indicators of stock outperformance.

What is Nyxoah SA's next-year EPS growth estimate?

As of 2026-08-13, Nyxoah SA (NYXH) has a next-year EPS growth estimate of 35.68%, based on analyst consensus.

When was the latest EPS estimate revision for NYXH?

The most recent revision occurred on 2026-08-09, when analysts adjusted the next-year EPS growth estimate from 34.79% to 35.68%.

What sector and industry does Nyxoah SA belong to?

Nyxoah SA operates in the Healthcare sector, specifically the Medical Instruments & Supplies industry.

How often is this EPS estimate data updated?

EPS revision data is refreshed daily from analyst consensus estimates. NYXH appears on this page because it was flagged by our daily top-EPS-revision-performer screen.

EPS revision data sourced from analyst consensus estimates, refreshed daily. Nyxoah SA (NYXH) appears here because it was detected by our daily top-EPS-revision-performer screen.